VivoSeq
Other

Adjuvant

0

Pipeline Programs↗

14

Active Trials↗

4

Companies Involved↗

Adjuvant is an early-stage landscape with 0 programs across 4 companies. The most active players are AstraZeneca, Bristol-Myers Squibb, Sanofi.

Intelligence

Pipeline Metrics

Competitive Density

31/100

Pipeline Velocity

15/100

Mech. Concentration

N/A

Completion Rate

77/100

Attrition Rate

15/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

AstraZeneca logo

AstraZeneca

0 programs

PreclinicalBristol-Myers Squibb logo

Bristol-Myers Squibb

0 programs

PreclinicalSanofi logo

Sanofi

0 programs

PreclinicalS

SpyBiotech Limited

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

62

clinical trials

Completed30 · 48%
Unknown status9 · 15%
Recruiting7 · 11%
Terminated6 · 10%
Active, not recruiting5 · 8%
Withdrawn3 · 5%
Other2 · 3%

Clinical Trials

Trial Activity

62 trials

Exercise as an Immune Adjuvant for Allogeneic Cell Therapies
Recruiting·UUniversity of Arizona·Phase 1·NCT06643221·100 enrolled
ATEMPT 2.0: Adjuvant T-DM1 vs TH
Recruiting·—·Phase 2·NCT04893109·500 enrolled
Perioperative FLOT vs Adjuvant XELOX for CA Stomach
Recruiting·—·Phase 3·NCT05264896·110 enrolled
Three Variants of the PENG Block With and Without Perineural Adjuvants in Older Adults
Recruiting·PPoznan University of Medical Sciences·N/A·NCT07330999·120 enrolled
InvaplexAR-Detox and DmLT Adjuvant in the Netherlands and Zambia
Recruiting·LLeiden University Medical Center·Phase 1·NCT05961059·85 enrolled
Renal Adjuvant MultiPle Arm Randomised Trial
Recruiting·UUniversity College, London·Phase 3·NCT03288532·1,750 enrolled
Dose Escalation Trial of CD40.Pan.CoV Vaccine, Adjuvanted or Not, as a Booster in Adult Healthy Volunteers
Recruiting·AANRS, Emerging Infectious Diseases·Phase 1/2·NCT07113106·48 enrolled
PALbociclib CoLlaborative Adjuvant Study
Active, not recruiting·AAlliance Foundation Trials, LLC.·Phase 3·NCT02513394·5,796 enrolled
Comparison of Intrathecal Nalbuphine Versus Intrathecal Tramadol as Adjuvants in Subarachnoid Block for Lower Limb Orthopaedic Surgeries
Active, not recruiting·—·N/A·NCT07294352·40 enrolled
The Safety and Tolerability of PGV001-based Personalized Multi-peptide Vaccines in the Adjuvant Setting.
Active, not recruiting·—·Phase 1·NCT05010200·27 enrolled
Adjuvant Avelumab in Merkel Cell Cancer
Active, not recruiting·UUniversity of Washington·Phase 3·NCT03271372·101 enrolled
Double Blind Placebo Controlled Controlled Study of Adjuvant MEDI4736 In Completely Resected NSCLC
Active, not recruiting·CCanadian Cancer Trials Group·Phase 3·NCT02273375·1,415 enrolled
Lipiodal Injection Technique for Free Flap Sparing Adjuvant RT Planning in HNC
Not yet recruiting·WWestern University, Canada·Phase 1·NCT06806189·10 enrolled
Adjuvant Intensification for LAR
Not yet recruiting·FFudan University·Phase 3·NCT07407517·904 enrolled
Secondary Adjuvant Long Term Study With Arimidex
Completed·AstraZeneca logoAstraZeneca·Phase 3·NCT00295620·3,484 enrolled
Page 1 of 5

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)